Original language | English |
---|---|
Pages (from-to) | 10-39 |
Number of pages | 30 |
Journal | Pharmacotherapy |
Volume | 39 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2019 |
Research programs
- EMC MM-04-28-01
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Pharmacotherapy, Vol. 39, No. 1, 2019, p. 10-39.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
AU - Tsuji, BT
AU - Pogue, JM
AU - Zavascki, AP
AU - Paul, M
AU - Daikos, GL
AU - Forrest, A
AU - Giacobbe, DR
AU - Viscoli, C
AU - Giamarellou, H
AU - Karaiskos, L
AU - Kaye, D
AU - Mouton, Johan
AU - Tam, VH
AU - Thamlikitkul, V
AU - Wunderink, RG
AU - Li, J (Jian)
AU - Nation, RL
AU - Kaye, KS
PY - 2019
Y1 - 2019
U2 - 10.1002/phar.2209
DO - 10.1002/phar.2209
M3 - Article
C2 - 30710469
SN - 0277-0008
VL - 39
SP - 10
EP - 39
JO - Pharmacotherapy
JF - Pharmacotherapy
IS - 1
ER -